Vymada 50mg Tablet

Vymada 50 mg Tablet is a prescription medicine used for the treatment of chronic heart failure with reduced ejection fraction (HFrEF). It contains Sacubitril, a neprilysin inhibitor, and Valsartan, an angiotensin II receptor blocker (ARB), which work together to improve heart function and reduce the workload on the heart. This combination helps the heart pump blood more efficiently, reduces fluid buildup, lowers blood pressure, and decreases the risk of heart failure-related hospitalization and cardiovascular death. Vymada also helps relieve symptoms such as breathlessness, tiredness, swelling of the feet, and reduced exercise tolerance. It is prescribed as part of a long-term heart failure treatment plan and should be taken regularly along with lifestyle modifications such as a low-salt diet, regular exercise as advised, fluid restriction when necessary, and routine medical follow-up for optimal heart health.

Vymada 50 mg Tablet combines Sacubitril 24 mg and Valsartan 26 mg to provide comprehensive treatment for chronic heart failure with reduced ejection fraction. Sacubitril blocks the enzyme neprilysin, increasing the levels of beneficial natriuretic peptides. These peptides help relax blood vessels, promote sodium and water excretion, reduce fluid overload, and decrease pressure on the heart. Valsartan, an angiotensin II receptor blocker, prevents blood vessel constriction and reduces the harmful effects of the renin-angiotensin-aldosterone system, lowering blood pressure and decreasing the heart's workload.

Together, these medicines improve cardiac output, reduce symptoms such as breathlessness, swelling, and fatigue, and significantly lower the risk of hospitalization and cardiovascular death. Long-term treatment with Vymada, combined with healthy lifestyle habits, medication adherence, routine monitoring, and appropriate management of other cardiovascular risk factors, helps slow the progression of heart failure and improves overall quality of life.

Precaution

• Use only under medical supervision.
• Do not use during pregnancy, as it may seriously harm the unborn baby.
• Inform your doctor if you have kidney disease, liver disease, or low blood pressure.
• Avoid potassium supplements or potassium-containing salt substitutes unless advised.
• Your doctor may regularly monitor blood pressure, kidney function, and potassium levels.
• Inform your doctor if you are taking ACE inhibitors, aliskiren, or other blood pressure medicines.

Storage

• Store below 30°C.
• Keep in a cool, dry place.
• Protect from moisture and direct sunlight.
• Keep the medicine in its original packaging.
• Keep out of reach of children.